GENEVA, Dec. 2 -- LA JOLLA INSTITUTE FOR IMMUNOLOGY (9420 Athena CircleLa Jolla, California 92037) filed a patent application (PCT/US2025/030661) for "KIR3DL2 AS AN ANTI-CANCER TARGET" on May 22, 2025. With publication no. WO/2025/245386, the details related to the patent application was published on Nov 27, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): AY, Ferhat (c/o La Jolla Institute for Immunology9420 Athena CircleLa Jolla, California 92037), CHAKRABORTY, Abhijit (c/o La Jolla Institute for Immunology9420 Athena CircleLa Jolla, California 92037)
Abstract: Provided herein are methods ...